His team is working with Smith Kline & French.

An earlier inquiry into dealings by another company, Smith Kline & French Laboratories, resulted in disciplinary actions.

Two years later he moved on to the pharmaceutical company Menley and James, which was later taken over by Smith Kline and French.

Instead Smith Kline chose just twenty-five key distributors, with whom it maintained far closer contact than was usual practice.

In 1951 he joined the pharmaceutical company Glaxo Laboratories, moving to Smith Kline and French in 1953.

"Even for the largest company to carve out a new program of 30 to 50 people is very hard; I couldn't have done it" at Smith Kline, he said.

Smith Kline and French, that entered into collaboration with Byk Gulden mid-1984, greatly assisted in determining criteria for further development.

His most outstanding achievement was the discovery of cimetidine, a drug used to combat stomach ulcers, when he was working at Smith Kline and French.

It changed its name to Smith Kline & French Laboratories as it focused more on research in 1929.

At the town meeting, the scientists faced a few skeptical questions about side effects and whether Smith Kline would pay the medical costs if patients had bad reactions.